SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16692ACNE!!!!!!!!!!!!!! ACNE!!!!!!!!!!!!!!! ACNE!!!!!!!!!!>>>>>http:Bluegreen-2/29/2004
16691250-300 million "eventual I assume" (from serono) is the latest estimaRobert K.-2/29/2004
16690From another article.> "For now, the biologics are the advance guard of Robert K.-2/29/2004
16689medscape.com and Introduction Severe Sepsis: Results of a Phase III, Multicenterdwight martin-2/28/2004
16688HEY BLUEGREEN >dont knock sepracor (I got a small bunch). Question> It loRobert K.-2/28/2004
16687When the Levy speaks, I listen. What was the Led Zepplin song. "when the leRobert K.-2/28/2004
16686CONCLUSION: BPI and HNP are accumulated in the synovial cavity of patients with Robert K.-2/28/2004
16685The ongoing research IS TRUELY AMAZING. Whats even MORE amazing, is that this isRobert K.-2/28/2004
16684I know of ONLY one potential remedy for bpi-anca. VBGRobert K.-2/28/2004
16683Or how about this (HCV= hepatitis C virus) The present study on chronic HCV infRobert K.-2/28/2004
16682I am ready for anytype of newer bpi trial. How to you spell inevitable? (but a lRobert K.-2/28/2004
16681And I am still very much thinking about this. Who would have ever thought? >Robert K.-2/28/2004
16680Now that Raptiva is approved, and novel, I can see treatment ideas (and actions)Robert K.-2/28/2004
16679And for our friends at DNA to consider....................... >>Br J PharmRobert K.-2/28/2004
16678Note the word "consistently disregarded" (familiar theme?) Med HypothRobert K.-2/28/2004
16677One thing I can say is that I do think jack is being honest in that they will taRobert K.-2/28/2004
16676Bob, WHY didn't Neuprex get at least conditional approval??? Why can't Bluegreen-2/28/2004
16675Page 37, refer to> >http://www.lejacq.com/pdinfo/JournalPages/SKIN-TOC.pdfRobert K.-2/28/2004
16674J Drugs Dermatol. 2004 Jan-Feb;3(1):77-9. Related Articles, Links GeneralizeRobert K.-2/28/2004
16673J Drugs Dermatol. 2004 Jan-Feb;3(1):27-38. Related Articles, Links Impact ofRobert K.-2/28/2004
16672"In conclusion, the magnitudes of inflammatory responses and bronchoconstriRobert K.-2/28/2004
16671"Likewise, testing the efficacy of the newly developed immunomodulatory ageRobert K.-2/28/2004
16670Interesting dating, interesting period. I wonder how much is promo and marketingRobert K.-2/27/2004
16669Hey Bob, how is this for VIP treatment!!!!!>>>>>> raptiva.comBluegreen-2/26/2004
16668Can you imagine how this might ROCK the Biotech world if Biotechs take on this cBluegreen-2/25/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News